Exhibit 10.1
|
|
Form B
|
|
|
For employees with
|
|
|
Change-In-Control
|
|
|
Agreements but not
|
|
|
Employment Agreements
|
|
Notice of Grant and Agreement and
Consent under the 1998 IMS Health
Incorporated Employees Stock
Incentive Plan
|
|
IMS Health Incorporated
|
|
|
|
ID: 06-1506026
901 Main Avenue
Norwalk, CT 06851
|
|
|
|
SAR Number:
|
|
|
|
|
Plan:
|
IH98
|
|
|
|
ID:
|
|
THIS DOCUMENT CONSTITUTES
PART OF A PROSPECTUS COVERING SECURITIES
THAT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933
IMS Health Incorporated (“IMS
HEALTH” or the “Company”) hereby grants to you a
stock appreciation right (“Stock Appreciation Rights”
or “SARs”) on
Shares of the Company’s common stock at the exercise price
per Share of
$ .
This grant is effective as of
(the “Grant Date”).
Your SARs are granted under the 1998 IMS Health
Incorporated Employees’ Stock Incentive Plan (the
“Plan”). The Plan is discretionary in nature and
IMS Health may amend, cancel or terminate the Plan at any
time. The grant of IMS HEALTH Stock Appreciation Rights is a
one-time benefit solely offered to employees and does not create
any contractual or other right for you to receive a grant of IMS
HEALTH stock appreciation rights or benefits in lieu of IMS HEALTH
stock appreciation rights in the future. Future grants, if
any, will be at the sole discretion of IMS HEALTH, including, but
not limited to, the timing of any grant, the number of IMS Health
Stock Appreciation Rights, vesting provisions and the exercise
price.
Each SAR entitles you, upon exercise, to an
amount (the “Stock Appreciation”) equal to (i) the
excess of (A) the Fair Market Value on the exercise date of
one Share over (B) the exercise price per Share, times
(ii) the number of Shares as to which you are exercising the
SAR. The future value of the underlying IMS HEALTH Shares is
unknown and cannot be predicted with certainty. If the
underlying IMS HEALTH Shares do not increase in value, you will
realize no value from your SARs.
Your SARs are subject to and governed by the
terms of the Plan. The provisions of the Plan are incorporated into
this Notice of Grant and Agreement and Consent
(“Agreement”) by reference. All capitalized terms
used in this Agreement but not defined shall have the meanings set
forth in the Plan. In the event the Plan and this Agreement
are not consistent, the terms of the Agreement shall govern,
including without limitation that the provisions related to
Termination of Employment as set out below shall prevail over any
inconsistent terms contained in the Plan. The SARs are
intended to be Non-409A Awards.
Your participation in the Plan and your
execution of this Agreement is voluntary. The value of IMS
HEALTH stock appreciation rights generally and your SARs
specifically are an extraordinary item of compensation outside the
scope of any employment contract you may have. As such,
neither IMS Health stock appreciation rights generally nor your
SARs specifically are part of normal or expected compensation for
purposes of calculating any termination, severance, resignation,
redundancy, end of
service payments, bonuses, long service awards,
pension or retirement benefits, or similar payments.
Your SARs and the terms thereof are subject to
adjustment as provided under Section 10(a) of the
Plan.
Stated Expiration Date, Vesting and Termination
of Employment
Your SARs will expire on the seventh anniversary
of the Grant Date (the “Stated Expiration Date”),
subject to earlier forfeiture or expiration as specified in clause
(a), (b), (c) or (d) below.
Your SARs will vest in four equal annual
installments on each of the first four anniversaries of the Grant
Date if your employment with the Company or a Subsidiary continues
through the applicable vesting date, subject to earlier vesting in
the following cases:
(a)
Notwithstanding anything to the
contrary in this Agreement, upon occurrence of a “Change in
Control” (as such term is defined in your Change in Control
Agreement), any unvested portion of your SARs not previously
forfeited or expired will become immediately exercisable. Upon your
termination of employment by the Company without Cause or by you
for Good Reason, as the terms “Cause” and “Good
Reason” are defined in your Change in Control Agreement, if
such termination occurs simultaneously with or within 24 months
following a Change in Control, the SARs shall be exercisable
thereafter until the Stated Expiration Date of the SARs.
(b)
If you have a Termination of
Employment (as defined below) due to death or Disability (as
defined in the Plan), the unexercised portion of the SARs shall
immediately vest in full (i.e., become non-forfeitable) and
(ii) your outstanding SARs may thereafter be exercised only
during the shorter of (1) the remaining period until the
Stated Expiration Date or (2) five years after the date of
Termination due to death or Disability.
(c)
If you have a Termination of
Employment by reason of Retirement, the unexercised portion of the
SARs may be exercised only during the shorter of (1) the
remaining period until the Stated Expiration Date or (2) five
years after the date of Retirement (the “Post-Retirement
Exercise Period”), provided that your SARs shall be
exercisable during such Post-Retirement Exercise Period only to the
extent the SARs were exercisable at the time of such
Retirement. The foregoing notwithstanding, (i) the
Committee may, in its sole discretion, accelerate the vesting of
the unvested portion of the SARs upon your Retirement, in which
case those previously unvested SARs shall not be forfeited as
provided herein but thereafter shall become exercisable to the
extent and at such times as such SARs would have become both vested
and exercisable during the Post-Retirement Exercise Period had your
employment not Terminated, unless the Committee specifies
otherwise; and (ii), in the event of your death within a period of
five years after such Retirement, your unexercised SARs (to the
extent not previously forfeited) may thereafter be exercised during
the shorter of the remaining Post-Retirement Exercise Period
or one year after the date of your death.
(d)
If you have a Termination of
Employment for any reason other than death, Disability or
Retirement, the unexercised portion of the SARs may be exercised
only during the period ending 90 days after the date of such
Termination of Employment, but only to the extent such SARs were
vested and exercisable at the time of such Termination of
Employment, and in no event may such SARs be exercised after the
Stated Expiration Date. The foregoing notwithstanding, the
Committee retains discretion to accelerate the vesting of unvested
SARs or specify post-termination exercise periods longer than
90 days, but not extending past the Stated Expiration
Date.
For purposes of this Agreement, a
“Termination of Employment” means your termination of
employment such that you are no longer in service to the Company or
any of its Subsidiaries,
including such a termination for any reason, and
whether occasioned by you, by the Company or a Subsidiary with or
without cause or by mutual agreement. Any portion of the SARs
not vested at or before Termination of Employment (or subject to
non-forfeiture in the case of Retirement pursuant to clause
(c) above) will be forfeited.
Exercise of
SARs
You may exercise your SARs at such time as they
have become vested only in accordance with the Plan and any
procedures that the Committee may approve from time to
time.
The date on which a notice of exercise is
received by the Company shall be the exercise date. Payment
shall be made to you upon exercise by delivery of a number of
Shares equal to the Stock Appreciation divided by the Fair Market
Value of one Share at the exercise date (subject to any applicable
tax withholding, as specified below). SARs may be exercised
from time to time upon actual receipt by the Company of written
notice of exercise stating the number of vested SARs being
exercised. Notwithstanding the foregoing, the Company may in
its sole discretion establish alternative means to exercise SARs,
including electronic forms using electronic signatures and
interactive voice response systems using PIN numbers, in a manner
directed by the Company, and your SARs shall be deemed to be
exercised upon fulfillment of such alternative means. You may
only exercise the SAR as to a given underlying Share one
time. Unless otherwise determined by the Company, no
fractional Shares will be issued in payment upon exercise of SARs
and the number of Shares to be delivered will be rounded downward
to the nearest whole Share. Upon exercise, you shall be paid,
in cash, an amount equal to the value of any fractional Share that
would have otherwise been payable at the time of exercise (after
giving effect to any Share withholding for mandatory taxes), unless
the Company arranges to deliver Shares to an account to which
fractional Shares may be credited without requiring the Company to
in fact issue a fractional Share.
If the SARs remain outstanding but unexercised
at the Stated Expiration Date or any earlier applicable date on
which the SARs would terminate, and if the Stock Appreciation at
that date would be a positive amount, the SARs, to the extent then
exercisable, shall be automatically exercised.
Other Provisions Relating to Termination or
Employment
Notwithstanding anything to the contrary, to the
extent that your Change in Control Agreement provides any
termination provisions that are more favorable to you (including
without limitation provisions relating to vesting and
post-termination exercise of options or SARs) than the Plan or this
Agreement, such provisions of your Change in Control Agreement
shall prevail and control, including in the event of your
termination by the Company without Cause or by you for Good
Reason or your termination due to death, disability or
Retirement. Conversely, to the extent that the Plan or this
Agreement provides any termination provisions that are more
favorable to you (including without limitation provisions relating
to vesting and post-termination exercise of options or SARs) than
your Change in Control Agreement, such provisions of the Plan or
this Agreement shall prevail and control, including in the event of
your termination by the Company without Cause or by you for Good
Reason or your termination due to death, disability or
Retirement.
You acknowledge and agree that you will have no
claim or entitlement (1) to compensation or damages in
consequence of the Termination of Employment with IMS Health or any
of its Subsidiaries for any reason whatsoever and whether or not in
breach of contract, insofar as such claim or entitlement arises or
may arise from your ceasing to have any rights under the Plan or
this Agreement, (2) to exercise your SARs as a result of such
Termination of Employment except as expressly provided in this
Agreement, or (3) from the loss or diminution in value of your
SARs; and, upon the grant of your SARs and in partial consideration
for your participation in the Plan and this Agreement, you shall be
deemed irrevocably to have waived any such claim or
entitlement.
Your sales of Shares acquired upon exercise of
your SARs will be subject to applicable restrictions under the
Company’s policies regulating insider trading by
employees.
Nontransferability of Your SARs
Except as may be provided otherwise under the
Plan, you cannot transfer, give, assign, sell, encumber, or in any
way transfer or alienate your SARs to anyone except after your
death by your will or by applicable inheritance laws, and during
your lifetime your SARs shall be exercisable only by you or your
legal representative.
Tax Withholding
It shall be a condition to the obligation of the
Company to issue and deliver Shares upon exercise of the SARs that
you (or any Beneficiary) pay to the Company (or a subsidiary or
affiliate), upon its demand, such amount as may be requested by the
Company for the purpose of satisfying the minimum statutory
withholding liabilities for federal, state, or local income and
other taxes. Unless otherwise determined by the Committee,
the Company shall withhold from the Shares to be delivered upon
exercise of the SARs that number of Shares having a fair market
value equal to the amount of such withholding tax liability (or as
nearly equal as possible without exceeding the amount of such tax
liability). For this purpose, the fair market value of the
withheld Shares shall be the average high/low sales prices in
composite trading of New York Stock Exchange-listed securities on
the day on which the Shares are withheld.
Forfeiture of Unexercised Portion of Your SARs
and Certain Gain
The greatest assets of IMS HEALTH and its
affiliates (each, an “IMS HEALTH Company”) are its
employees, technology and customers. In recognition of the
increased risk of unfairly losing any of these assets to its
competitors, IMS HEALTH has adopted the following
policy:
If you directly or indirectly engage in any of
the “Detrimental Activities” defined below:
(a)
any unexercised portion of your SARs
shall automatically expire (regardless of vesting) on the later of
the date of your Termination of Employment or the date IMS HEALTH
becomes aware of your Detrimental Activity; and
(b)
you shall forfeit to the Company the
Shares acquired upon any exercise of your SARs by you during the
one year prior to, or at any time after, the date of the earliest
actual occurrence of your Detrimental Activity (the
“Forfeiture Period”). Such Shares shall be
forfeited by you and payable to the Company at the later of
(i) the date of your Termination of Employment or
(ii) the date of your Detrimental Activity. If you have
disposed of the Shares during the Forfeiture Period, your
obligation to repay Shares upon such forfeiture will continue
(payment of cash or other property is not permitted), so that you
will be required to acquire replacement Shares and deliver them to
the Company in settlement of your forfeiture obligation without
regard to any subsequent market price increase or decrease from the
date of exercise. If you fail to promptly deliver forfeited
Shares and if, apart from this Agreement, the Company is obligated
to pay any cash amount to you, the Company, as a setoff, may use
such cash to purchase Shares in the open market on your behalf,
which Shares will be retained by the Company in settlement of your
forfeiture obligation hereunder.
Detrimental Activities are defined
as:
·
using or disclosing any information
that has been treated by an IMS HEALTH Company as confidential or
proprietary and is of competitive advantage to such IMS HEALTH
Company, unless you are using or disclosing it in the course of
your job with such IMS HEALTH Company;
·
during the period beginning the
Grant Date and ending twelve months after you leave your employment
with any IMS HEALTH Company (the “Prohibited Period”),
soliciting, inducing, enticing or procuring for anyone other than
an IMS HEALTH Company the trade or business of any entity that was
a customer (including “near-permanent” customers),
prospective customer or data supplier of an IMS HEALTH Company, in
order to sell to such customer or prospective
customer, or obtain from such data
supplier, the same, similar or related services IMS HEALTH offers
to its customers, or such data supplier provided to IMS HEALTH,
during the period that you worked for any IMS HEALTH
Company;
·
during the Prohibited Period,
soliciting, inducing, enticing or procuring any employee of any IMS
HEALTH Company to leave his or her employment; or employing or
otherwise using the services of any person who is or was an IMS
HEALTH Company employee during the last twelve months that you
worked for an IMS HEALTH Company; or
·
during the Prohibited Period,
directly or indirectly (including without limitation as an officer,
director, employee, advisor, agent, consultant or investor, other
than by the ownership of a passive investment interest of not more
than 1% in a company with publicly traded equity securities),
(i) seeking or accepting any employment or other work with or
providing assistance to any person or entity that offers
Competitive Services (as defined below) to any person or entity
that was a customer or potential customer of any IMS HEALTH Company
at any time during the last two years of your employment with any
IMS HEALTH Company, or (ii) otherwise providing Competitive
Services.
For purposes hereof, “Competitive
Services” means engaging in the following activities anywhere
in the world in relation to the pharmaceutical and healthcare
industries (it being understood that the global market in which any
of the businesses of IMS is conducted and to which their goodwill
extends is not limited to any particular region in the world and
that given the informational nature of such businesses, they may be
engaged effectively from any location in the world):
·
providing information services for
the management of sales forces engaged in the sale of prescription
or over-the-counter drugs, medical devices, or medical or surgical
products;
·
providing information services for
the measurement of sales force performance or product performance
for prescription or over-the-counter drugs, medical devices, or
medical or surgical products;
·
creating or providing physician
profiles for purposes of assisting others in the targeting of
promotion or sales activities in relation to prescription or
over-the-counter drugs, medical devices, or medical or surgical
products;
·
creating or providing micromarketing
programs based on prescribing behavior or attitudes of physicians
or other prescribers in relation to prescription or
over-the-counter drugs, medical devices, or medical or surgical
products;
·
creating or providing market
research reports or audits relating to the use, sale,
marketing/promotion, distribution or warehousing of any
prescription or over-the-counter drugs, medical devices, or medical
or surgical products;
·
using or developing technology,
methodologies or processes which have functionality or produce
results similar to the technology, methodologies or processes
employed or offered by IMS HEALTH to process pharmaceutical or
healthcare information, including but not limited to internal
processing technology, decision support tools, data warehousing
applications and data mining applications;
·
creating or providing reference
files, classification schemes, master files or other methods of
categorizing, classifying, organizing or identifying products,
procedures, medical facilities, pharmacies, warehouses,
distributors, prescribers, pharmacists or other entities,
activities or persons associated with the use, sale,
marketing/promotion, distribution or warehousing of any
prescription or over-the-counter drugs, medical devices, or medical
or surg